Research Focus: Targeting Tropomyosin Receptor Kinases in Cancer

In this educational activity with an accompanying PowerPoint slideset Todd M. Bauer MD provides his expert perspective on the biological rationale for targeting TRK in the treatment of diverse cancers with NTRK gene fusions including a review of the latest clinical data on investigational TRK inhibitors.

Share

Program Content

Activities

TRK Inhibitors in Cancer
Research Focus: Targeting Tropomyosin Receptor Kinases in Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 16, 2018

Expires: April 15, 2019

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Loxo Oncology